drugset / Trial / NCT00734734
Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009
NaSingle-groupOpen-labelPrevention
Summary
Trial for annual approval of interpandemic influenza vaccines
Timeline
- Start
- 2008-06
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quadrivalent influenza vaccine | Vaccine | — | Intramuscular |
Indications
No indication recorded.